National HIV/AIDS Conference Takes Place in Atlanta, Oct. 11-12

Article

ATLANTA -- Results from the scientific study, HEDS UP (HIV Early Detection Study of Unrecognized Positives), will be unveiled at a national HIV/AIDS Conference on Friday, Oct. 11 and Saturday, Oct. 12 at the Swissotel in Buckhead.

The HEDS UP study found that 40 percent of patients diagnosed with HIV have already progressed to AIDS before HIV was detected, despite having known risk factors or clinical symptoms associated with the disease. The study was conducted by Kaiser Permanente and Group Health Cooperative of Washington state.

The HIV/AIDS Conference, sponsored by Kaiser Permanente, will provide a forum for clinicians to present and discuss the latest research and treatments for HIV patients. Statistically, more than 36 million people worldwide are infected with HIV. Other key conference highlights:

Recent advances in HIV/AIDS therapies and research, including the T-20 class drug

Discussion about United States' response to the global AIDS epidemic and a call to activism

The impact of HIV/AIDS on Africa

The role of resistance testing

Long-term complications of antiretrovirals

In conjunction with the conference, a fundraiser will take place on Friday, Oct. 11, from 6-8 p.m. at the Swissotel for AID Atlanta, a local organization that serves people living with HIV and AIDS. To register, call Lisa Crouse at (770) 777-1115 by Tuesday, Oct. 1. Visit www.kaiserpermanente.org/kphiv/ for more information.

Source: PRNewswire

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
Bug of the Month
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.